I4V-MC-JAIX - ClinicalTrials.gov - NCT03559270
I4V-MC-JAIX - ClinicalTrials.gov - NCT03559270
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed at least 16 weeks of treatment in study JAIW prior to discontinuation
Female participants must not be pregnant or breastfeeding
Participants must be willing to commit to using birth control for the duration of the study, unless pregnancy is not possible for the participant or the participants female sexual partner
Participants must NOT
Participants must not be enrolled in other studies that may not be compatible with study JAIX.
Participants must not have uncontrolled high blood pressure, heart attack, chest pain, stroke, heart failure or any other serious or unstable disease or infection
Trial Summary
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
Baricitinib
Could I receive a Placebo?
no
Enrollment Goal
300
Trial Dates
June 2018 - December 2021
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed at least 16 weeks of treatment in study JAIW prior to discontinuation
Female participants must not be pregnant or breastfeeding
Participants must be willing to commit to using birth control for the duration of the study, unless pregnancy is not possible for the participant or the participants female sexual partner
Participants must NOT
Participants must not be enrolled in other studies that may not be compatible with study JAIX.
Participants must not have uncontrolled high blood pressure, heart attack, chest pain, stroke, heart failure or any other serious or unstable disease or infection
Trial Summary
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
Baricitinib
Could I receive a Placebo?
no
Enrollment Goal
300
Trial Dates
June 2018 - December 2021
Trial Phase
3
Trial Locations
Hide locations not currently recruiting